Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XXIV.v

Radiation recall pneumonitis

(Fr: PnP de rappel en territoire préalablement irradié). Radiation recall pneumonitis is when pulmonary opacities develop exactly in the previously-irradiated area of the chest and lung, following the administration of adriamycin, carmustine, doxorubicin, etoposide, gefitinib, gemcitabine, paclitaxel or trastuzumab. Radiation recall on the skin and esophagus can also occur (PMID 24965480)

Publications

Shinada K, Murakami S, Yoshida D, Saito H

Radiation recall pneumonitis after COVID-19 vaccination.

Thoracic cancer 2021 Nov 17;; — 2021 Nov 17

Hughes NM, Hammer MM, Awad MM, Jacene HA

Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination.

Clinical nuclear medicine 2021 Nov 02;; — 2021 Nov 02

Steber CR, Ponnatapura J, Hughes RT, Farris MK

Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.

Cureus 2021 Apr 05;13;e14303 — 2021 Apr 05 — e14303